References
- Matsumoto J L, Miyamoto T, Minamida A., . Structure activity relationships of 4-oxo-l,8-naphthyridine-3-carboxylic acids including AT-2266, a new oral antipseudomonal agent. Current Chemotherapy and Infectious Disease, J D Nelson, C Grassi, et al. American Society for Microbiology, Washington, DC 1980; 454–6
- Nakamura S, Takase Y, Kurobe N, Kashimoto S, Shimizu M. Pharmacological properties of AT-2266. Current Chemotherapy and Infectious Disease, J D Nelson, C Grassi. American Society for Microbiology, Washington, DC 1980; 456–8
- Wise R, Lockley R, Dent J, Webberly M. Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother 1984; 26: 17–9
- Chartrand S A, Scribner R K, Weber A H, Welch D F, Marks M I. In vitro activity of CI-919 (AT-2266), an anti-pseudomonal compound. Antimicrob Agents Chemother 1983; 23: 658–63
- Chin Nai-Xun Neu H C. In vitro activity of enoxacin, a quinolone carboxylic acid compared with those of norfloxacin, new β-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother 1983; 24: 754–63
- Nakamura S, Minami A, Katae H., et al. In vitro antibacterial properties of AT-2266, a new pyridone-carboxylic acid. Antimicrob Agents Chemother 1983; 23: 641–8
- Nakamura S, Nakata K, Katae H., et al. Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid and gentamicin against various experimental infections in mice. Antimicrob Agents Chemother 1983; 23: 742–9
- Shimizu M, Takase Y, Nakamura S., . AT-2266, a new oral antipseudomonal agent. Current Chemotherapy and Infectious Disease, J D Nelson, C Grassi, et al. American Society for Microbiology, Washington, DC 1980; 451–4
- Wise R, Andrews J M, Danks G. In vitro activity of enoxacin (CI-919), a new quinoline derivative compared with that of other antimicrobial agents. J Antimicrob Chemother 1984; 13: 237–44
- Cowan S T, Steel K J. Cowan and Steel's manual for the identification of medical bacteria, 2nd Ed. Cambridge University Press, CambridgeUK 1974; 4
- Skirrow M M, Benjamin. Differentiation of enteropathogenic Campylobacter. J Clin Pathol 1980; 33: 1122
- Young H, Paterson I C, McDonald D R. Rapid carbohydrate utilization test for the identification of Neisseria gonorrhoeae. Brit J Vener Dis 1976; 52: 172–5
- Washington J A, II. Laboratory procedures in clinical microbiology. Springer Verlag, New York 1981
- Young H. Cutural diagnosis of gonorrhoea with modified New York City (MNYC) medium. Brit J Vener Dis 1978; 54: 36–40
- Hawkey P M. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium. J Antimicrob Chemother 1984; 13: 209–26
- Hubrechts J M, Vanhoof R, Servais J., et al. Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin. Lancet 1984; 1: 860